JP2019216843A - Wet sheet - Google Patents
Wet sheet Download PDFInfo
- Publication number
- JP2019216843A JP2019216843A JP2018114693A JP2018114693A JP2019216843A JP 2019216843 A JP2019216843 A JP 2019216843A JP 2018114693 A JP2018114693 A JP 2018114693A JP 2018114693 A JP2018114693 A JP 2018114693A JP 2019216843 A JP2019216843 A JP 2019216843A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- less
- wet sheet
- chemical
- wet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47K—SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR; TOILET ACCESSORIES
- A47K7/00—Body washing or cleaning implements
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47L—DOMESTIC WASHING OR CLEANING; SUCTION CLEANERS IN GENERAL
- A47L13/00—Implements for cleaning floors, carpets, furniture, walls, or wall coverings
- A47L13/10—Scrubbing; Scouring; Cleaning; Polishing
- A47L13/16—Cloths; Pads; Sponges
- A47L13/17—Cloths; Pads; Sponges containing cleaning agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Cleaning Implements For Floors, Carpets, Furniture, Walls, And The Like (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、ウェットシートに関する。 The present invention relates to a wet sheet.
手の汚れの除去や清掃等に用いられる除菌効果を有するウェットシートとしては、大別して、含浸させる薬液にアルコールが含まれるものと、含まれないものとがあるが、従来、アルコールが含まれないものにおいては、除菌活性値を向上するために、プロピレングリコール及びパラベンを使用していた。しかし、プロピレングリコール及びパラベンを使用すると、薬液が使用者の肌に付着した際にべたつきを感じることがあった。
そこで、薬液にアルコールが含まれず、かつプロピレングリコール及びパラベンを使用しない、除菌効果を有するウェットシートが知られている（例えば、特許文献１参照）。
Wet sheets having a disinfecting effect used for removing stains on hands, cleaning, etc. are roughly classified into those containing alcohol and those not containing alcohol in a chemical solution to be impregnated. In those which did not, propylene glycol and paraben were used to improve the eradication activity value. However, when propylene glycol and paraben are used, the liquid medicine sometimes feels sticky when attached to the skin of the user.
Therefore, there is known a wet sheet which does not contain alcohol in a chemical solution and does not use propylene glycol and paraben and has a disinfecting effect (for example, see Patent Document 1).
しかしながら、特許文献１に記載の発明においては、プロピレングリコール及びパラベンを含有しないものの、いまだ使用者が感じるべたつきの低減は十分ではなかった。 However, in the invention described in Patent Document 1, although propylene glycol and paraben are not contained, reduction of stickiness felt by a user has not been sufficient yet.
本発明は、上記課題に鑑みてなされたものであって、十分な除菌力を有しつつ、使用者がべたつきを感じにくいウェットシートを提供することを目的とする。 The present invention has been made in view of the above-described problems, and has as its object to provide a wet sheet that has a sufficient sterilizing power and makes it difficult for a user to feel sticky.
上記課題を解決するため、請求項１に記載の発明は、
シート体に薬液を含浸させたウェットシートであって、
前記薬液は、
グレープフルーツ種子エキスを含有し、大腸菌及び黄色ブドウ球菌に対する除菌活性値が２．０以上であり、
接触角が４３°以下であることを特徴とする。
本発明によれば、十分な除菌力を有しつつ、使用者がべたつきを感じにくいウェットシートを提供することができる。
In order to solve the above problems, the invention described in claim 1 is
A wet sheet in which a sheet body is impregnated with a chemical solution,
The chemical is
Contains a grapefruit seed extract, the eradication activity value against Escherichia coli and Staphylococcus aureus is 2.0 or more,
The contact angle is 43 ° or less.
Advantageous Effects of Invention According to the present invention, it is possible to provide a wet sheet that has a sufficient disinfecting power and does not allow a user to feel sticky.
請求項２に記載の発明は、請求項１に記載のウェットシートであって、
前記薬液は、
99.0質量％以上の水と、
1.0×10-2質量％以上、5.0×10-2質量％以下のグレープフルーツ種子エキスと、
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸と、
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸ナトリウムと、
1.0×10-2質量％以上、5.0×10-1質量％以下の塩化ベンザルコニウムと、
1.0×10-2質量％以上、5.0×10-2質量％以下の塩化セチルピリジニウムと、
1.0×10-3質量％以上、5.0×10-2質量％以下のポリアミノプロピルビグアニドと、
を含有することを特徴とする。
本発明によれば、十分な除菌力を有しつつ、使用者がべたつきを感じにくいウェットシートを提供することができる。
The invention according to claim 2 is the wet sheet according to claim 1,
The chemical is
99.0% by mass or more of water,
A grapefruit seed extract of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less,
1.0 × 10 −3 mass% or more and 5.0 × 10 −3 mass% or less of citric acid;
1.0 × 10 −3 mass% or more and 5.0 × 10 −3 mass% or less of sodium citrate,
1.0 × 10 -2 mass% or more and 5.0 × 10 -1 mass% or less benzalkonium chloride;
Cetylpyridinium chloride of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less,
1.0 × 10 −3 mass% or more and 5.0 × 10 −2 mass% or less of polyaminopropyl biguanide,
It is characterized by containing.
Advantageous Effects of Invention According to the present invention, it is possible to provide a wet sheet that has a sufficient disinfecting power and does not allow a user to feel sticky.
請求項３に記載の発明は、請求項２に記載のウェットシートであって、
前記薬液は、1.0×10-3質量％以上、5.0×10-2質量％以下のオレンジエキスを含有することを特徴とする。
本発明によれば、さらにべたつき難さを改善できる。
The invention according to claim 3 is the wet sheet according to claim 2,
The medicinal solution is characterized by containing an orange extract of 1.0 × 10 −3 mass% or more and 5.0 × 10 −2 mass% or less.
According to the present invention, it is possible to further reduce the stickiness.
請求項４に記載の発明は、請求項１から３のいずれか一項に記載のウェットシートであって、
前記シート体は、引張強度が、ＭＤ方向に４５Ｎ以上、ＣＤ方向に１０Ｎ以上であることを特徴とする。
本発明によれば、ウェットシートを十分な強度とすることができる。
The invention according to claim 4 is the wet sheet according to any one of claims 1 to 3,
The sheet body has a tensile strength of 45 N or more in the MD direction and 10 N or more in the CD direction.
According to the present invention, the wet sheet can have sufficient strength.
本発明によれば、十分な除菌力を有しつつ、使用者がべたつきを感じにくいウェットシートを提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, a user can provide a wet sheet which has sufficient sanitizing power and is hard for a user to feel sticky.
以下、本発明の実施形態であるウェットシートについて詳細に説明する。ただし、本発明の技術的範囲は、これに限定されるものではない。 Hereinafter, the wet sheet according to the embodiment of the present invention will be described in detail. However, the technical scope of the present invention is not limited to this.
［実施形態の構成］
｛全体構成｝
本実施形態のウェットシートは、シート体に薬液が含浸されたものである。
[Configuration of Embodiment]
{overall structure}
The wet sheet of the present embodiment is obtained by impregnating a sheet with a chemical solution.
｛シート体｝
本発明において用いるシート体としては、後述の薬液を含浸させることができるものであれば、特に限定はないが、柄のない不織布であり、かつ引張強度（長辺１００ｍｍ、短辺５０ｍｍの試験片を長辺方向に引っ張り、これが破断したときの最大点荷重によって測定した値（株式会社エー・アンド・ディー製のTENSILON RTG−1210を用いた。））が、抄紙機上の紙の進行方向（ＭＤ方向）に４５Ｎ以上であり、抄紙機上の紙の進行方向と直角な方向（ＣＤ方向）に１０Ｎ以上であることが望ましい。
｛Sheet body｝
The sheet used in the present invention is not particularly limited as long as it can be impregnated with a chemical solution described later, but is a non-woven fabric having no handle and a tensile strength (a test piece having a long side of 100 mm and a short side of 50 mm). In the direction of the long side, and the value measured by the maximum point load when this was broken (using TENSILON RTG-1210 manufactured by A & D Co., Ltd.) It is preferably 45 N or more in the MD direction) and 10 N or more in the direction (CD direction) perpendicular to the traveling direction of the paper on the paper machine.
また、シート体を構成する原料繊維としては、レーヨン、ＰＥＴ（ポリエチレンテレフタレート）等を用いたものであることが望ましい。 Further, it is desirable that the raw material fibers constituting the sheet body are those using rayon, PET (polyethylene terephthalate) or the like.
また、シート体の目付は、２０〜８０ｇｓｍであることが好ましい。なお、目付は、ＪＩＳ Ｐ ８１２４：２０１１に従って測定した坪量をいう。 Further, the basis weight of the sheet is preferably 20 to 80 gsm. The basis weight refers to the basis weight measured according to JIS P 8124: 2011.
｛薬液｝
薬液としては、以下のものを用いる。
なお、薬液含浸率は５０質量％以上、４００質量％以下であることが好ましい。なお薬液含浸率とは、薬液含浸前のシート体の質量と、含浸させる薬液の質量とを測定し、薬液含浸前のシート体の質量に対する含浸させる薬液の質量の割合を算出したものをいう。
｛Chemical solution｝
The following are used as chemicals.
The chemical liquid impregnation rate is preferably 50% by mass or more and 400% by mass or less. The chemical impregnation rate refers to a value obtained by measuring the mass of the sheet before impregnation with the chemical and the mass of the chemical to be impregnated, and calculating the ratio of the mass of the chemical to be impregnated to the mass of the sheet before impregnation with the chemical.
薬液としては接触角が４３°以下のものを用いる。接触角が３６°以下のものを用いることがさらに好ましい。
なお、接触角は、固液界面解析システム（協和界面科学株式会社のDrop Master 300）を用いて液滴法にて測定を行った。具体的には、上記システムに付属のシリンジを用いて、液滴をアルミ製の台の表面に接触させて着滴させた後、自動的にパソコンに取得した画像の解析を行い、接触角を算出した。
A chemical having a contact angle of 43 ° or less is used. It is more preferable to use one having a contact angle of 36 ° or less.
The contact angle was measured by a droplet method using a solid-liquid interface analysis system (Drop Master 300 of Kyowa Interface Science Co., Ltd.). Specifically, using the syringe attached to the above-mentioned system, the droplet is brought into contact with the surface of the aluminum base and allowed to deposit, and then the image acquired by the personal computer is automatically analyzed to determine the contact angle. Calculated.
また、清掃時の除菌効果を十分なものとするため、除菌力が９９％以上である必要がある。
なお、ここで除菌力が９９％以上とは、大腸菌及び黄色ブドウ球菌の両者に対して、除菌活性値が２．０以上であることをいう。なお、除菌活性値の測定は、一財社団法人 日本衛生材料工業連合会編、「ウエットワイパー類の除菌性能試験方法」（平成27年11月16日改定）に準じて行った。
具体的には、適当な汚れと共に細菌を試験担体（ステンレス板）に接種し、乾燥後拭取り装置に設置する。試験試料（ウエットワイプまたは対照液を塗布した綿布）を巻きつけたおもりで試験担体上を所定回数拭取り、5分間静置する。5分後、試験担体を不活性化剤に移し、試験試料の細菌の増殖を抑制したり死滅させる性質を不活性化させた後、試験担体上の生菌数を測定する。
試験試料の除菌活性値は、対照試料及び試験試料で拭取り後、それぞれの試験担体上に残存する生菌数の常用対数値の差で示す。
In addition, in order to achieve a sufficient sterilization effect during cleaning, the sterilization power needs to be 99% or more.
Here, the term “99% or more of the bactericidal power” means that the bactericidal activity value is 2.0 or more against both Escherichia coli and Staphylococcus aureus. The measurement of the disinfecting activity was carried out in accordance with "Testing method of disinfecting wet wipes" (revised on November 16, 2015), edited by the Japan Sanitary Material Federation.
Specifically, bacteria are inoculated on a test carrier (stainless steel plate) together with an appropriate stain, and after drying, the bacteria are placed in a wiping device. A test sample (a wet wipe or a cotton cloth coated with a control solution) is wrapped around the test carrier with a weight, and the sample is allowed to stand for 5 minutes. After 5 minutes, the test carrier is transferred to an inactivating agent to inactivate the property of the test sample that inhibits or kills bacterial growth, and then the number of viable bacteria on the test carrier is measured.
The eradication activity value of the test sample is represented by the difference between the common logarithmic value of the number of viable bacteria remaining on each test carrier after wiping with the control sample and the test sample.
このような薬液としては、具体的には、例えば以下の６成分を含有し、これら６成分の含有量の合計が1.0質量％以下であり、水の含有量が99.0質量％以上であるものを用いることができる。
1.0×10-2質量％以上、5.0×10-2質量％以下のグレープフルーツ種子エキス
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸ナトリウム
1.0×10-2質量％以上、5.0×10-1質量％以下の塩化ベンザルコニウム
1.0×10-2質量％以上、5.0×10-2質量％以下の塩化セチルピリジニウム
1.0×10-3質量％以上、5.0×10-2質量％以下のポリアミノプロピルビグアニド
Specifically, such a chemical solution contains, for example, the following six components, and the total content of these six components is 1.0% by mass or less, and the water content is 99.0% by mass or more. Can be used.
Grapefruit seed extract of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less
1.0 × 10 -3 mass% or more and citric acid of 5.0 × 10 -3 mass% or less
1.0 × 10 -3 mass% or more and 5.0 × 10 -3 mass% or less sodium citrate
1.0 × 10 -2 mass% or more and 5.0 × 10 -1 mass% or less benzalkonium chloride
Cetylpyridinium chloride of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less
1.0 × 10 -3 mass% or more and 5.0 × 10 -2 mass% or less of polyaminopropyl biguanide
グレープフルーツ種子エキスは、抗菌作用を有することから含有されているものである。
クエン酸は、pH調整及び緩衝作用を有することから含有されているものである。
クエン酸ナトリウムは、pH調整及び緩衝作用を有することから含有されているものである。
塩化ベンザルコニウムは、抗菌作用を有することから含有されているものである。
塩化セチルピリジニウムは、抗菌作用を有することから含有されているものである。
ポリアミノプロピルビグアニドは、抗菌作用を有することから含有されているものである。
Grapefruit seed extract is contained because it has an antibacterial effect.
Citric acid is included because it has a pH adjusting and buffering action.
Sodium citrate is included because it has a pH adjusting and buffering action.
Benzalkonium chloride is contained because it has an antibacterial effect.
Cetylpyridinium chloride is contained because it has an antibacterial effect.
Polyaminopropyl biguanide is included because it has an antibacterial effect.
また、薬液はさらに、1.0×10-3質量％以上、5.0×10-2質量％以下のオレンジエキスを含有していてもよい。 Further, the chemical solution may further contain 1.0 × 10 −3 mass% or more and 5.0 × 10 −2 mass% or less of orange extract.
｛実施形態の効果｝
十分な除菌効果を有するウェットシートを、アルコールを含有しない薬液を用いて製作した場合、従来のものにおいては、使用者が感じるべたつきを十分に低減できなかった。
これに対して、本実施形態によれば、薬液の接触角が上記の範囲であることによって、使用者の手肌等に付着した薬液が広がり易くなり、アルコールを含有せずとも、これが蒸発し易くなる。
したがって、アルコールを含有しない薬液を用いた場合においても、十分な除菌効果を有しつつ、使用者が感じるべたつきを低減することが可能となる。
<< Effects of the Embodiment >>
When a wet sheet having a sufficient sanitizing effect is manufactured using a chemical solution containing no alcohol, the conventional one cannot sufficiently reduce the stickiness felt by the user.
On the other hand, according to the present embodiment, when the contact angle of the drug solution is in the above range, the drug solution attached to the user's hand skin or the like becomes easy to spread, and even if it does not contain alcohol, it evaporates. It will be easier.
Therefore, even when a chemical solution containing no alcohol is used, it is possible to reduce the stickiness felt by the user while having a sufficient sterilizing effect.
次に、本発明の実施例及び比較例に係るウェットシートにつき、除菌力の評価、接触角測定及びべたつき等に関する評価を行った結果について説明する。 Next, the results of the evaluation of the sterilization power, the measurement of the contact angle, the evaluation of stickiness, and the like for the wet sheets according to Examples and Comparative Examples of the present invention will be described.
［実施例及び比較例の構成］
以下の実施例及び比較例に係るウェットシートを用意した。
[Configuration of Examples and Comparative Examples]
Wet sheets according to the following examples and comparative examples were prepared.
｛実施例１｝
（シート体）
大きさ：ＭＤ方向200ｍｍ、ＣＤ方向150ｍｍ
成分：レーヨン：40質量％、ＰＥＴ（ポリエチレンテレフタレート）：40質量％、ＰＥ（ポリエチレン）及びＰＰ（ポリプロピレン）の混合物：20質量％
構成：スパンレース不織布
目付：３４ｇ／ｍ２
（薬液）
精製水：99.434％
塩化ベンザルコニウム50％水溶液：1.0×10-1％
（塩化ベンザルコニウム: 5.0×10-2％）
塩化セチルピリジニウム：3.0×10-2％
ポリアミノプロピルビグアニド20％水溶液：1.0×10-1％
（ポリアミノプロピルビグアニド: 2.0×10-2％）
グレープフルーツ種子エキス：1.0×10-2％
フェノキシエタノール：3.0×10-1％
クエン酸：5.0×10-3％
クエン酸ナトリウム：1.0×10-3％
アロエエキス：1.0×10-2％
グリセリン：1.0×10-2％
（薬液含浸率）
２５０％
<< Example 1 >>
(Sheet body)
Size: MD direction 200mm, CD direction 150mm
Ingredients: rayon: 40% by mass, PET (polyethylene terephthalate): 40% by mass, mixture of PE (polyethylene) and PP (polypropylene): 20% by mass
Composition: Spunlace nonwoven fabric basis weight: 34 g / m 2
(Chemical solution)
Purified water: 99.434%
Benzalkonium chloride 50% aqueous solution: 1.0 × 10 -1 %
(Benzalkonium chloride: 5.0 × 10 -2 %)
Cetylpyridinium chloride: 3.0 × 10 -2 %
20% aqueous solution of polyaminopropyl biguanide: 1.0 × 10 -1 %
(Polyaminopropyl biguanide: 2.0 × 10 -2 %)
Grapefruit seed extract: 1.0 × 10 -2 %
Phenoxyethanol: 3.0 × 10 -1 %
Citric acid: 5.0 × 10 -3 %
Sodium citrate: 1.0 × 10 -3 %
Aloe extract: 1.0 × 10 -2 %
Glycerin: 1.0 × 10 -2 %
(Drug impregnation rate)
250%
｛実施例２｝
（シート体）
実施例１と同様。
（薬液）
精製水：99.424％
塩化ベンザルコニウム50％水溶液：1.0×10-1％
（塩化ベンザルコニウム: 5.0×10-2％）
塩化セチルピリジニウム：3.0×10-2％
ポリアミノプロピルビグアニド20％水溶液：1.0×10-1％
（ポリアミノプロピルビグアニド: 2.0×10-2％）
グレープフルーツ種子エキス：1.0×10-2％
フェノキシエタノール：3.0×10-1％
クエン酸：5.0×10-3％
クエン酸ナトリウム：1.0×10-3％
アロエエキス：1.0×10-2％
グリセリン：1.0×10-2％
オレンジエキス：1.0×10-2％
（薬液含浸率）
実施例１と同様。
<< Example 2 >>
(Sheet body)
Same as in the first embodiment.
(Chemical solution)
Purified water: 99.424%
Benzalkonium chloride 50% aqueous solution: 1.0 × 10 -1 %
(Benzalkonium chloride: 5.0 × 10 -2 %)
Cetylpyridinium chloride: 3.0 × 10 -2 %
20% aqueous solution of polyaminopropyl biguanide: 1.0 × 10 -1 %
(Polyaminopropyl biguanide: 2.0 × 10 -2 %)
Grapefruit seed extract: 1.0 × 10 -2 %
Phenoxyethanol: 3.0 × 10 -1 %
Citric acid: 5.0 × 10 -3 %
Sodium citrate: 1.0 × 10 -3 %
Aloe extract: 1.0 × 10 -2 %
Glycerin: 1.0 × 10 -2 %
Orange extract: 1.0 × 10 -2 %
(Drug impregnation rate)
Same as in the first embodiment.
｛実施例３｝
（シート体）
実施例１と同様。
（薬液）
精製水：99.404％
塩化ベンザルコニウム50％水溶液：1.0×10-1％
（塩化ベンザルコニウム: 5.0×10-2％）
塩化セチルピリジニウム：3.0×10-2％
ポリアミノプロピルビグアニド20％水溶液：1.0×10-1％
（ポリアミノプロピルビグアニド: 2.0×10-2％）
グレープフルーツ種子エキス：3.0×10-2％
フェノキシエタノール：3.0×10-1％
クエン酸：5.0×10-3％
クエン酸ナトリウム：1.0×10-3％
アロエエキス：1.0×10-2％
グリセリン：1.0×10-2％
オレンジエキス：1.0×10-2％
（薬液含浸率）
実施例１と同様。
Example 3
(Sheet body)
Same as in the first embodiment.
(Chemical solution)
Purified water: 99.404%
Benzalkonium chloride 50% aqueous solution: 1.0 × 10 -1 %
(Benzalkonium chloride: 5.0 × 10 -2 %)
Cetylpyridinium chloride: 3.0 × 10 -2 %
20% aqueous solution of polyaminopropyl biguanide: 1.0 × 10 -1 %
(Polyaminopropyl biguanide: 2.0 × 10 -2 %)
Grapefruit seed extract: 3.0 × 10 -2 %
Phenoxyethanol: 3.0 × 10 -1 %
Citric acid: 5.0 × 10 -3 %
Sodium citrate: 1.0 × 10 -3 %
Aloe extract: 1.0 × 10 -2 %
Glycerin: 1.0 × 10 -2 %
Orange extract: 1.0 × 10 -2 %
(Drug impregnation rate)
Same as in the first embodiment.
｛比較例１｝
（シート体）
実施例１と同様。
（薬液）
精製水：96.184％
プロピレングリコール：3.0％
塩化ベンザルコニウム50％水溶液：1.0×10-1％
（塩化ベンザルコニウム: 5.0×10-2％）
塩化セチルピリジニウム：3.0×10-2％
ポリアミノプロピルビグアニド20％水溶液：1.0×10-1％
（ポリアミノプロピルビグアニド: 2.0×10-2％）
グレープフルーツ種子エキス：1.0×10-2％
パラオキシ安息香酸メチル：2.0×10-1％
パラオキシ安息香酸エチル：5.0×10-2％
パラオキシ安息香酸プロピル：2.0×10-2％
フェノキシエタノール：3.0×10-1％
クエン酸：5.0×10-3％
クエン酸ナトリウム：1.0×10-3％
（薬液含浸率）
実施例１と同様。
<< Comparative Example 1 >>
(Sheet body)
Same as in the first embodiment.
(Chemical solution)
Purified water: 96.184%
Propylene glycol: 3.0%
Benzalkonium chloride 50% aqueous solution: 1.0 × 10 -1 %
(Benzalkonium chloride: 5.0 × 10 -2 %)
Cetylpyridinium chloride: 3.0 × 10 -2 %
20% aqueous solution of polyaminopropyl biguanide: 1.0 × 10 -1 %
(Polyaminopropyl biguanide: 2.0 × 10 -2 %)
Grapefruit seed extract: 1.0 × 10 -2 %
Methyl paraoxybenzoate: 2.0 × 10 -1 %
Ethyl paraoxybenzoate: 5.0 × 10 -2 %
Propyl paraoxybenzoate: 2.0 × 10 -2 %
Phenoxyethanol: 3.0 × 10 -1 %
Citric acid: 5.0 × 10 -3 %
Sodium citrate: 1.0 × 10 -3 %
(Drug impregnation rate)
Same as in the first embodiment.
［試験方法］
上記実施例及び比較例に係るウェットシートを用いて、以下の試験を行った。
[Test method]
The following tests were performed using the wet sheets according to the above Examples and Comparative Examples.
｛除菌力試験｝
上記実施例及び比較例に用いられた薬液について、大腸菌及び黄色ブドウ球菌の２菌種に関する除菌活性値の測定を行った。
具体的には、段落００１８に示した方法を用いた。
菌 Bactericidal test｝
With respect to the drug solutions used in the above Examples and Comparative Examples, the bactericidal activity values of two species of Escherichia coli and Staphylococcus aureus were measured.
Specifically, the method shown in paragraph 0018 was used.
｛接触角測定｝
上記実施例及び比較例に用いられた薬液について、接触角の測定を行った。
具体的には、段落００１７に示した方法を用いた。
｛Contact angle measurement｝
The contact angles of the chemical solutions used in the above Examples and Comparative Examples were measured.
Specifically, the method shown in paragraph 0017 was used.
｛べたつき等の評価｝
上記実施例及び比較例に係るウェットシートについて、被験者８人に実際に手肌を拭かせ、べたつき難さ、乾き易さ、耐久性、拭き易さ、汚れ落ちにつき、１から７の７段階で評価させ、その平均値を算出した。なお、４を平均（一般的なウェットシート程度）として、極めて良好な場合に７、極めて不良な場合を１とし、平均よりやや良好な場合を５、平均よりやや不良な場合を３とし、平均より良好な場合を６、平均より不良な場合を２とした。
｝ Evaluation of stickiness 等
Regarding the wet sheets according to the above Examples and Comparative Examples, eight subjects actually wiped their hand skin, and were difficult to stick, easy to dry, durable, easy to wipe, and stain removal in seven steps from 1 to 7. Evaluation was performed and the average value was calculated. In addition, 4 is an average (about a general wet sheet), 7 is extremely good, 1 is extremely poor, 5 is slightly better than average, 3 is slightly poorer than average, and 3 is average. The case where it was better was 6 and the case where it was worse than the average was 2.
［試験結果］
試験の結果を表Ｉに示す。
[Test results]
The results of the test are shown in Table I.
［評価］
実施例と比較例との比較から、ウェットシートに含浸させる薬液の接触角を小さくすることによって、べたつき難さ、乾き易さ、拭き易さ、汚れ落ちを改善できることが分かる。
[Evaluation]
From the comparison between the examples and the comparative examples, it can be seen that by reducing the contact angle of the chemical solution impregnated in the wet sheet, it is possible to improve the difficulty of stickiness, the ease of drying, the ease of wiping, and the removal of dirt.
Claims (4)
前記薬液は、
グレープフルーツ種子エキスを含有し、大腸菌及び黄色ブドウ球菌に対する除菌活性値が２．０以上であり、
接触角が４３°以下であることを特徴とするウェットシート。 A wet sheet in which a sheet body is impregnated with a chemical solution,
The chemical is
Contains a grapefruit seed extract, the eradication activity value against Escherichia coli and Staphylococcus aureus is 2.0 or more,
A wet sheet having a contact angle of 43 ° or less.
99.0質量％以上の水と、
1.0×10-2質量％以上、5.0×10-2質量％以下のグレープフルーツ種子エキスと、
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸と、
1.0×10-3質量％以上、5.0×10-3質量％以下のクエン酸ナトリウムと、
1.0×10-2質量％以上、5.0×10-1質量％以下の塩化ベンザルコニウムと、
1.0×10-2質量％以上、5.0×10-2質量％以下の塩化セチルピリジニウムと、
1.0×10-3質量％以上、5.0×10-2質量％以下のポリアミノプロピルビグアニドと、
を含有することを特徴とする請求項１に記載のウェットシート。 The chemical is
99.0% by mass or more of water,
A grapefruit seed extract of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less,
1.0 × 10 −3 mass% or more and 5.0 × 10 −3 mass% or less of citric acid;
1.0 × 10 −3 mass% or more and 5.0 × 10 −3 mass% or less of sodium citrate,
1.0 × 10 -2 mass% or more and 5.0 × 10 -1 mass% or less benzalkonium chloride;
Cetylpyridinium chloride of 1.0 × 10 -2 mass% or more and 5.0 × 10 -2 mass% or less,
1.0 × 10 −3 mass% or more and 5.0 × 10 −2 mass% or less of polyaminopropyl biguanide,
The wet sheet according to claim 1, further comprising:
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018114693A JP7089413B2 (en) | 2018-06-15 | 2018-06-15 | Wet wipes |
| PCT/JP2019/022711 WO2019240031A1 (en) | 2018-06-15 | 2019-06-07 | Wet sheet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018114693A JP7089413B2 (en) | 2018-06-15 | 2018-06-15 | Wet wipes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019216843A true JP2019216843A (en) | 2019-12-26 |
| JP7089413B2 JP7089413B2 (en) | 2022-06-22 |
Family
ID=68841953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018114693A Active JP7089413B2 (en) | 2018-06-15 | 2018-06-15 | Wet wipes |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7089413B2 (en) |
| WO (1) | WO2019240031A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022025226A1 (en) * | 2020-07-31 | 2022-02-03 | 有限会社ジーエヌコーポレーション | Microbicide composition |
| WO2022181457A1 (en) * | 2021-02-24 | 2022-09-01 | レック株式会社 | Wipe sheet and aqueous composition for impregnating wipe sheet |
| WO2023228604A1 (en) * | 2022-05-24 | 2023-11-30 | 大王製紙株式会社 | Cleansing wet wipe |
| KR20240012348A (en) | 2021-05-24 | 2024-01-29 | 다이오세이시가부시끼가이샤 | cleaning wet sheets |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001206818A (en) * | 1999-11-12 | 2001-07-31 | Pigeon Corp | Chemical solution for wet tissue and packaged wet tissue |
| JP2009131474A (en) * | 2007-11-30 | 2009-06-18 | Daio Paper Corp | Wet tissue |
| JP2015148023A (en) * | 2014-02-06 | 2015-08-20 | ダイワボウホールディングス株式会社 | Non-woven fabric for wet sheet, wet wiping sheet, and liquid-impregnated skin coating sheet |
| JP2017124060A (en) * | 2016-01-14 | 2017-07-20 | 日本製紙クレシア株式会社 | Wet tissue roll body |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197322B1 (en) * | 1997-12-23 | 2001-03-06 | Kimberly-Clark Worldwide, Inc. | Antimicrobial structures |
-
2018
- 2018-06-15 JP JP2018114693A patent/JP7089413B2/en active Active
-
2019
- 2019-06-07 WO PCT/JP2019/022711 patent/WO2019240031A1/en active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001206818A (en) * | 1999-11-12 | 2001-07-31 | Pigeon Corp | Chemical solution for wet tissue and packaged wet tissue |
| JP2009131474A (en) * | 2007-11-30 | 2009-06-18 | Daio Paper Corp | Wet tissue |
| JP2015148023A (en) * | 2014-02-06 | 2015-08-20 | ダイワボウホールディングス株式会社 | Non-woven fabric for wet sheet, wet wiping sheet, and liquid-impregnated skin coating sheet |
| JP2017124060A (en) * | 2016-01-14 | 2017-07-20 | 日本製紙クレシア株式会社 | Wet tissue roll body |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022025226A1 (en) * | 2020-07-31 | 2022-02-03 | 有限会社ジーエヌコーポレーション | Microbicide composition |
| WO2022181457A1 (en) * | 2021-02-24 | 2022-09-01 | レック株式会社 | Wipe sheet and aqueous composition for impregnating wipe sheet |
| KR20240012348A (en) | 2021-05-24 | 2024-01-29 | 다이오세이시가부시끼가이샤 | cleaning wet sheets |
| WO2023228604A1 (en) * | 2022-05-24 | 2023-11-30 | 大王製紙株式会社 | Cleansing wet wipe |
| EP4505936A4 (en) * | 2022-05-24 | 2025-07-02 | Daio Seishi Kk | CLEANSING WET WIPE |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019240031A1 (en) | 2019-12-19 |
| JP7089413B2 (en) | 2022-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019216843A (en) | Wet sheet | |
| KR870002047B1 (en) | Composition and product for eradication of virus | |
| JP6254531B2 (en) | Bactericidal composition and method of using the bactericidal composition | |
| US4045364A (en) | Iodophor soap tissues | |
| JP5689817B2 (en) | Chlorhexidine acetate disinfectant cleaner | |
| JP6425660B2 (en) | Improved antimicrobial composition | |
| JP7078819B2 (en) | Wet wiper | |
| JP6795889B2 (en) | Wet wipe roll | |
| JP2009256338A (en) | Sterilizing disinfectant-containing wet wiper | |
| CN110477792A (en) | A kind of nonalcoholic wet tissue and preparation method thereof can be used for breathing mask cleaning-sterilizing | |
| US8357392B2 (en) | Dry antiseptic wipes comprising an amphoteric surfactant | |
| JP7270368B2 (en) | wet sheet | |
| WO2022109061A1 (en) | Sanitizing compositions containing ionic liquid | |
| JP2017203021A (en) | Sterilizing composition | |
| JPH072615A (en) | Cloth impregnated with antimicrobial disinfectant | |
| US12018233B2 (en) | Wet wipes with a combination of glycines for improved preservative properties | |
| JP6796910B2 (en) | Wet wiper | |
| JPH10324624A (en) | Disinfectant composition | |
| JPH0337017A (en) | Wet tissue | |
| JP2014218443A (en) | Antibacterial agent composition and cleaning sheet using the same | |
| JP3628122B2 (en) | Wet sheet | |
| JP4632810B2 (en) | Cleaning sheet | |
| CN101453888A (en) | Alcohol-containing antimicrobial compositions having improved efficacy | |
| KR20060103817A (en) | Method to inhibit the proliferation of antibiotic resistant bacteria using pentane-1,5-diol | |
| JP3871779B2 (en) | Cleaning composition and fiber sheet impregnated with the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210514 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220322 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220404 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220607 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220610 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7089413 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |